Multiple Australian outlets report criticism that the Therapeutic Goods Administration’s oversight of medical devices is not meeting expectations. The articles describe the current regulatory regime as deeply flawed, arguing that shortcomings in how medical devices are assessed, monitored, or governed leave gaps in assurance about safety and effectiveness. While the sources share the same core claim—that the TGA’s medical devices oversight is inadequate—they provide limited additional detail in the supplied excerpts. Overall, the coverage frames the issue as a systemic regulatory problem rather than an isolated case, calling attention to concerns about whether existing processes provide adequate safeguards for patients and healthcare providers. The articles align on the central message: reforms are needed to improve the way medical devices are regulated in Australia. The reporting focuses on the regulator’s role and performance, rather than on specific incidents or individual devices, based on the information provided.